Hi, I'm Oliver, the Editor for our Online Content. Feel free to email me at editorial.dept@lawyer-monthly.com if you have any questions or interesting content to send over!
The Solicitors’ Charity has launched a new survey and needs the legal profession’s contribution to be able to shape its support as it looks forward to recovering from COVID-19.
As of 2020, Merck & Co.’s Keytruda (also known as Pembrolizumab) has been approved for use in metastatic mesothelioma patients to diminish tumour volume, but only if they have certain specific genetic markers. It is most effective when it’s used in combination with other therapies, but even then its effect is moderate at best.
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent